$26.03 0.00 (0.00%)
Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 31, 2025 | $0.74 | 2025-07-15 | 2025-07-15 |
| April 30, 2025 | $0.74 | 2025-04-15 | 2025-04-15 |
| January 31, 2025 | $0.74 | 2025-01-15 | 2025-01-15 |
| October 31, 2024 | $0.74 | 2024-10-15 | 2024-10-15 |
| July 31, 2024 | $0.74 | 2024-07-15 | 2024-07-15 |
Dividends Summary
- Harrow, Inc. 11.875% Senior Notes due 2027 has issued 11 dividend payments over the past 2 years
- The most recent dividend was paid 85 days ago, on July 31, 2025
- The highest dividend payed out to investors during this period was $0.74 per share
- The average dividend paid during this period was $0.71 per share.
Company News
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?
Harrow Inc. announced the acquisition of Melt Pharmaceuticals, a clinical-stage company developing a non-opioid sedation tablet (MELT-300) for medical procedures. The company plans to submit a New Drug Application to the FDA in 2027, targeting a U.S. launch in 2028.
Harrow to Acquire Melt Pharmaceuticals
Harrow plans to acquire Melt Pharmaceuticals for its MELT-300 sedation therapy, a non-opioid sublingual medication designed to provide rapid sedation for medical procedures. The acquisition aims to expand Harrow's procedural sedation market presence and offer an alternative to traditional IV sedation.